BioCentury | Jan 8, 2021
Finance

More strategics pile into Dutch early-stage investor BGV’s largest-ever fund

...NYSE:LLY) and Novo Holdings A/S’s venture arm join existing investors Bristol Myers Squibb Co. (NYSE:BMY), Schroder Adveq...
BioCentury | Nov 14, 2020
Product Development

Complete response for Sanofi’s rare anemia candidate; plus Sumitovant-Urovant, C4-Roche, IN8bio and Synendos

...A co-led by Kurma Partners and Sunstone Life Science Ventures with participation from BERNINA BioInvest, Schroder Adveq...
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...preclinical and clinical development. 4BIO Capital, btov Partners and existing investors Redalpine, VI Partners and Schroder Adveq...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...by Casdin Capital and Tavistock Group’s Boxer Capital. New investors Eli Lilly and Co. (NYSE:LLY), Schroder Adveq...
BioCentury | Sep 10, 2020
Finance

Casma to advance muscle dystrophy candidate into the clinic with $50M series B

...well as new investors Eventide Asset Management, Schroder Adveq...
...Group Merck & Co. Inc. Third Rock Ventures Eventide Asset Management Schroder Adveq Calporta...
BioCentury | Jun 24, 2020
Finance

Expect more company creation by BGV with its €105M fourth fund

...return backers such as Bristol Myers Squibb Co. (NYSE:BMY), the European Investment Fund (EIF) and Schroder Adveq...
BioCentury | May 11, 2020
Finance

Third Rock-backed fibrosis company Pliant joins IPO queue

...investor syndicate also includes Farallon Capital Management, Cormorant Asset Management, Citadel’s Surveyor Capital, Logos Capital, Schroder Adveq...
BioCentury | Mar 3, 2020
Finance

Pliant to advance rare fibrosis pipeline with Novartis-led $100M C round

...Management, Surveyor Capital and Logos Capital and existing investors Eventide Asset Management, Cowen Healthcare Investments, Schroder Adveq...
BioCentury | Jan 24, 2020
Finance

iOnctura taps European syndicate for series A to bring two ‘best-in-class’ programs to the clinic

...the round’s leader, and Switzerland’s VI Partners as the co-leader. Also participating were new investor Schroder Adveq...
BioCentury | Dec 11, 2019
Financial News

Dec. 10 Financial Quick Takes: Inscripta, Aurinia, Akeso, Ribo, Hummingbird, ImmunOs, Peregrine

...in a series A round co-led by BioMedPartners and Pfizer Ventures, with participation by Redalpine, Schroder Adveq...
Items per page:
1 - 10 of 29
BioCentury | Jan 8, 2021
Finance

More strategics pile into Dutch early-stage investor BGV’s largest-ever fund

...NYSE:LLY) and Novo Holdings A/S’s venture arm join existing investors Bristol Myers Squibb Co. (NYSE:BMY), Schroder Adveq...
BioCentury | Nov 14, 2020
Product Development

Complete response for Sanofi’s rare anemia candidate; plus Sumitovant-Urovant, C4-Roche, IN8bio and Synendos

...A co-led by Kurma Partners and Sunstone Life Science Ventures with participation from BERNINA BioInvest, Schroder Adveq...
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...preclinical and clinical development. 4BIO Capital, btov Partners and existing investors Redalpine, VI Partners and Schroder Adveq...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...by Casdin Capital and Tavistock Group’s Boxer Capital. New investors Eli Lilly and Co. (NYSE:LLY), Schroder Adveq...
BioCentury | Sep 10, 2020
Finance

Casma to advance muscle dystrophy candidate into the clinic with $50M series B

...well as new investors Eventide Asset Management, Schroder Adveq...
...Group Merck & Co. Inc. Third Rock Ventures Eventide Asset Management Schroder Adveq Calporta...
BioCentury | Jun 24, 2020
Finance

Expect more company creation by BGV with its €105M fourth fund

...return backers such as Bristol Myers Squibb Co. (NYSE:BMY), the European Investment Fund (EIF) and Schroder Adveq...
BioCentury | May 11, 2020
Finance

Third Rock-backed fibrosis company Pliant joins IPO queue

...investor syndicate also includes Farallon Capital Management, Cormorant Asset Management, Citadel’s Surveyor Capital, Logos Capital, Schroder Adveq...
BioCentury | Mar 3, 2020
Finance

Pliant to advance rare fibrosis pipeline with Novartis-led $100M C round

...Management, Surveyor Capital and Logos Capital and existing investors Eventide Asset Management, Cowen Healthcare Investments, Schroder Adveq...
BioCentury | Jan 24, 2020
Finance

iOnctura taps European syndicate for series A to bring two ‘best-in-class’ programs to the clinic

...the round’s leader, and Switzerland’s VI Partners as the co-leader. Also participating were new investor Schroder Adveq...
BioCentury | Dec 11, 2019
Financial News

Dec. 10 Financial Quick Takes: Inscripta, Aurinia, Akeso, Ribo, Hummingbird, ImmunOs, Peregrine

...in a series A round co-led by BioMedPartners and Pfizer Ventures, with participation by Redalpine, Schroder Adveq...
Items per page:
1 - 10 of 29